Please use this identifier to cite or link to this item:
|Title:||Management of B-cell non-Hodgkin lymphoma in Asia: Resource-stratified guidelines||Authors:||Tan, D.
|Issue Date:||Nov-2013||Citation:||Tan, D., Tan, S.Y., Lim, S.T., Kim, S.J., Kim, W.-S., Advani, R., Kwong, Y.-L. (2013-11). Management of B-cell non-Hodgkin lymphoma in Asia: Resource-stratified guidelines. The Lancet Oncology 14 (12) : e548-e561. ScholarBank@NUS Repository. https://doi.org/10.1016/S1470-2045(13)70450-9||Abstract:||Treatment of B-cell non-Hodgkin lymphomas has undergone substantial developments in the past 10 years. The introduction of rituximab has greatly improved survival outcomes in patients. Clinical practice guidelines based on current evidence have been developed to provide recommendations for standard treatment approaches. However, guidelines do not take into account resource limitations in resource-poor countries. The huge disparities in economy, health-care infrastructure, and access to novel drugs between Asian countries can hinder the delivery of optimum care to patients with lymphoma in Asia. We outline guidelines appropriate to different levels of health-care resources and expertise, aiming to provide advice on diagnosis and treatment, unify interpretation of results, and allow the design of future studies in Asia. In this resource-adapted consensus, we summarise recommendations for diagnosis, staging, risk stratification, and treatment of common B-cell non-Hodgkin lymphomas in Asia. © 2013 Elsevier Ltd.||Source Title:||The Lancet Oncology||URI:||http://scholarbank.nus.edu.sg/handle/10635/124852||ISSN:||14702045||DOI:||10.1016/S1470-2045(13)70450-9|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 10, 2021
WEB OF SCIENCETM
checked on Jun 3, 2021
checked on Jun 6, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.